Abstract:Microphthalmia (MITF) gene product, a transcription factor of the basic-helix-loop-helix type, is thought to play a role in the regulation of genes encoding the enzymes necessary for melanogenesis. These include tyrosinase, TRP-1 and TRP-2. Melanocyte-specific isoform of microphthalmia, MITF-M, is expressed in normal and malignant melanocytes. The presence of two other isoforms of microphthalmia, MITF-A and MITF-H, which differ from MITF-M in the amino-terminus, was demonstrated also in some non-melanocytic lineages. Here we have analyzed the presence of all three known isoforms of MITF mRNA in a panel of 17 human melanoma cell lines by a reverse transcriptase-polymerase chain reaction using isoform-specific primers. While, as expected, the predominant form in melanoma cell lines was MITF-M, low amounts of MITF-A mRNA was found in almost all melanomas, as well as in most of 20 tumor cell lines of the non-melanocyte origin (lung and colon carcinomas, osteosarcomas and neuroblastomas). The expression of MITF-H was not detected, with a few exceptions, in the tested cell lines. Pax3 transcription factor was reported earlier to regulate positively the melanocyte-specific promoter of the MITF gene. We found here that the Pax 3 mRNA was expressed in all melanoma cell lines, even in those that had repressed the MITF-M and were amelanotic. This suggests that additional factors, besides Pax3, are required for the MITF expression. The MSG1 (melanocyte-specific gene 1), a gene originally isolated from melanocytes and containing a strong transcription activation domain, was also found expressed in all melanomas and most non-melanocyte tumor cell lines. Together, these data indicate that the MITF-M isoform is the major type of MITF mRNA present in human melanoma cell lines and show that the expression of the isoform MITF-A and the MSG1 is not restricted to malignant melanocytes and occurs in a wide range of tumor cell lines.

Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas

Microphthalmia-Associated Transcription Factor (MITF): Multiplicity in Structure, Function, and Regulation

MITF: master regulator of melanocyte development and melanoma oncogene

Mitf-Mdel, a Novel Melanocyte/melanoma-Specific Isoform of Microphthalmia-Associated Transcription Factor-M, As a Candidate Biomarker for Melanoma

MITF: A Stream Flowing for Pigment Cells

Lipocalin-type Prostaglandin D Synthase As a Melanocyte Marker Regulated by MITF.

Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi

MITF reprograms the extracellular matrix and focal adhesion in melanoma

MITF in melanoma: mechanisms behind its expression and activity

MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species

“Transcription physiology” of pigment formation in melanocytes: central role of MITF

Incomplete Expression of the Tyrosinase Gene Family (tyrosinase, Trp-1, and Trp-2) in Human Malignant Melanoma Cells in Vitro

In Vivo Role of Alternative Splicing and Serine Phosphorylation of the Microphthalmia-Associated Transcription Factor

Investigation of downstream target genes of PAX3c, PAX3e and PAX3g isoforms in melanocytes by microarray analysis

Mitf over-expression leads to microphthalmia and coloboma in Mitf-cre mice

The changes of microRNA expression profiles and tyrosinase related proteins in MITF knocked down melanocytes

Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.

Endolysosomal Cation Channels and MITF in Melanocytes and Melanoma

The MITF regulatory network in melanoma

MITF-M regulates melanogenesis in mouse melanocytes

Expression and Significance of MITF-M Transcripts in Clear Cell Sarcoma of Soft Tissue